Details
Stereochemistry | ACHIRAL |
Molecular Formula | H3NO |
Molecular Weight | 33.0299 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NO
InChI
InChIKey=AVXURJPOCDRRFD-UHFFFAOYSA-N
InChI=1S/H3NO/c1-2/h2H,1H2
Molecular Formula | H3NO |
Molecular Weight | 33.0299 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effect of inactivation by hydroxylamine on early functions of poliovirus. | 1971 Jul |
|
Central effects of endogenous and exogenous GABA. | 1978 May-Jun |
|
Availability of dinitrophenylated lipid haptens for specific antibody binding depends on the physical properties of host bilayer membranes. | 1982 Jun 10 |
|
Acute neurotoxicity of sodium azide and nitric oxide. | 1991 Jul |
|
Sulfamethoxazole is metabolized to the hydroxylamine in humans. | 1992 May |
|
Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. | 1993 Nov |
|
Nitroxide radical biostability in skin. | 1993 Oct |
|
Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma. | 1993 Oct 19 |
|
Stratum corneum intercellular lipid as compared to erythrocyte ghosts: an ESR study of thermotropic behavior and nitroxide reduction. Electron Spin Resonance. | 1995 |
|
Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime. | 1997 Aug |
|
Nitric oxide ameliorates actinomycin D/endotoxin-induced apoptotic liver failure in mice. | 1999 Aug |
|
Gas chromatographic-mass spectrometric analysis of hydroxylamine for monitoring the metabolic hydrolysis of metalloprotease inhibitors in rat and human liver microsomes. | 1999 Mar 5 |
|
The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives. | 1999 Nov 1 |
|
Molecular diffusion into ferritin: pathways, temperature dependence, incubation time, and concentration effects. | 2000 Apr |
|
Paraquat induces different pulmonary biochemical responses in Wistar rats and Swiss mice. | 2000 Mar 1 |
|
N-t-Butyl hydroxylamine is an antioxidant that reverses age-related changes in mitochondria in vivo and in vitro. | 2001 Oct |
|
Developmental differences in the immortalization of lung fibroblasts by telomerase. | 2003 Oct |
|
NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. | 2004 Dec |
|
Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism. | 2005 Jul |
|
Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients. | 2006 May |
|
In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv. | 2009 Sep |
|
Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast. | 2011 Jun |
|
Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1. | 2012 Aug 20 |
|
Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity. | 2013 Feb 25 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:24:25 GMT 2023
by
admin
on
Fri Dec 15 17:24:25 GMT 2023
|
Record UNII |
2FP81O2L9Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7803-49-8
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
DTXSID7041043
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
D019811
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
232-259-2
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
m6137
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
787
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
15429
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
579
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
300000046412
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
2FP81O2L9Z
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY | |||
|
HYDROXYLAMINE
Created by
admin on Fri Dec 15 17:24:25 GMT 2023 , Edited by admin on Fri Dec 15 17:24:25 GMT 2023
|
PRIMARY |